Max Healthcare Q2 FY27 Results and Expansion Approvals
Max Healthcare Institute Ltd · Change in Management · 30 Oct 2026, 8:27 pm
Max Healthcare Q2 FY27 Results and Expansion Approvals Max Healthcare Institute reported consolidated revenue from operations of ₹2,56,921 lakh for the quarter ended 30th Sep'26, up 20.31% YoY, with net profit after tax reaching ₹41,445 lakh (PAT attributable to owners at ₹41,494 lakh). The board approved capex via subsidiary Crosslay Remedies: ~₹93 crore to add ~85 beds at MSSH Noida within 15 months, and ~₹97 crore to add ~60 beds at MSSH Vaishali within 24 months. Additionally, the Sector-56 Gurugram hospital project cost was revised to ~₹1,143 crore, targeted for completion by Apr'27.
Original exchange filing (PDF)
More announcements from Max Healthcare Institute Ltd
- Presentation for Investor Conference · 14 Nov 2026
- Transcript of Earnings Call held on November 3, 2026 · 10 Nov 2026
- Schedule of Investor Conference · 05 Nov 2026
- Audio Recording of Earnings Call held on November 3, 2026 · 04 Nov 2026
- Disclosure under regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 · 04 Nov 2026
- Presentation of earnings update for the quarter and half year ended September 30, 2026 · 30 Oct 2026
- Press Release - Max Healthcare Q2 revenue rises to Rs. 3,219 Cr, registering growth of 20% YoY; Q2 PAT stood at Rs. 448 Cr, growth of 10% YoY · 30 Oct 2026
- Outcome of Board Meeting held on October 30, 2026 · 30 Oct 2026
